New Antimicrobials For The Present And The Future
Download New Antimicrobials For The Present And The Future full books in PDF, epub, and Kindle. Read online free New Antimicrobials For The Present And The Future ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : I.W. Fong |
| Publisher | : Springer Nature |
| Total Pages | : 247 |
| Release | : 2023-06-26 |
| Genre | : Medical |
| ISBN | : 3031260783 |
This is a timely and essential companion to the recently published Antimicrobial Resistance in the 21st Century, Second Edition. Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO's top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade. Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparison. This volume is designed for researchers and students of infectious disease and medical microbiology, as well as clinicians in need of a comprehensive guide to newly developed agents.
| Author | : National Research Council |
| Publisher | : National Academies Press |
| Total Pages | : 102 |
| Release | : 2006-01-03 |
| Genre | : Medical |
| ISBN | : 0309180686 |
Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic.
| Author | : Chika Ejikeugwu |
| Publisher | : Independently Published |
| Total Pages | : 0 |
| Release | : 2022-09-26 |
| Genre | : |
| ISBN | : |
This book introduces antimicrobials and biotechnology, considering these from the focus of pharmaceutical microbiology. This focus offers an alternative perspective to the more traditional clinical focus. Hence, there is a strong emphasis upon research and development as well as drug efficacy. A major theme is antimicrobial agents (and the role played by pharmaceutical microbiologists in developing and delivering these agents) and the growth in microbial resistance. In the last two decades, the rate at which bacteria are becoming resistant to current antibiotic treatments has substantially increased. This trend is threatening the ability of medical staff to carry out routine operations or transplants in the future. This has been compounded not only by microorganisms that are resistant to one antimicrobial or another, but due to the rise of multi-drug resistant microorganisms (the so-termed 'super bugs'). The book traces the development of antimicrobials and contextualises the different types that are available. Later the text looks at how natural and synthetic antibacterial agents work and describes the problems that resistance present for the next generation of scientists who will be required to develop new and more effective treatments. For the generation of alternatives, an understanding of biotechnology is required and hence this subject area represents another major theme considered throughout the text.
| Author | : Thomas J. Dougherty |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 1119 |
| Release | : 2011-12-18 |
| Genre | : Medical |
| ISBN | : 1461414008 |
This volume covers all aspects of the antibiotic discovery and development process through Phase II/III. The contributors, a group of highly experienced individuals in both academics and industry, include chapters on the need for new antibiotic compounds, strategies for screening for new antibiotics, sources of novel synthetic and natural antibiotics, discovery phases of lead development and optimization, and candidate compound nominations into development. Beyond discovery , the handbook will cover all of the studies to prepare for IND submission: Phase I (safety and dose ranging), progression to Phase II (efficacy), and Phase III (capturing desired initial indications). This book walks the reader through all aspects of the process, which has never been done before in a single reference. With the rise of antibiotic resistance and the increasing view that a crisis may be looming in infectious diseases, there are strong signs of renewed emphasis in antibiotic research. The purpose of the handbook is to offer a detailed overview of all aspects of the problem posed by antibiotic discovery and development.
| Author | : I. W. Fong |
| Publisher | : Springer |
| Total Pages | : 774 |
| Release | : 2018-11-10 |
| Genre | : Medical |
| ISBN | : 3319785389 |
This comprehensive, up-to-date volume defines the issues and offers potential solutions to the challenges of antimicrobial resistance. The chapter authors are leading international experts on antimicrobial resistance among a variety of bacteria, viruses including HIV and herpes, parasites and fungi. The chapters explore the molecular mechanisms of drug resistance, the immunology and epidemiology of resistance strains, clinical implications and implications on research and lack thereof, and prevention and future directions.
| Author | : Sergio Sánchez |
| Publisher | : Caister Academic Press Limited |
| Total Pages | : 0 |
| Release | : 2015 |
| Genre | : Medical |
| ISBN | : 9781908230546 |
The 'golden age' for antibiotic discovery, from 1940 until the early 1970s, ushered in a new era in human- and animal-health and the associated dramatic increase in human life expectancies. Indeed, the possibility of eradicating infectious disease seemed feasible. However, it soon became apparent that microorganisms wouldn't be defeated so easily. Their weapon: antibiotic resistance. Today, microbial antibiotic resistance is rapidly exhausting the supply of effective compounds, and this makes the possibility of a global public health disaster seem likely. The urgency of this situation has spawned a plethora of new multi-disciplinary research initiatives looking for novel antibiotics and other antimicrobial agents. In this timely book, respected international experts summarize the most important research to provide a timely overview of the field. Opening chapters define 'antibiotic,' explain why we need new compounds, outline the applications of antibiotics, both old and new, and describe the producing microbes. These are followed by chapters that cover antibiotic resistance, toxicity, overuse, new antimicrobial sources, new targets, novel technologies for antibiotic discovery (e.g. silent gene clusters), lantibiotics, natural antivirals, new macrolide derivatives, and antibiotics in the pipeline. The book will be essential reading for everyone working in antimicrobial research, biotechnology companies, and the pharmaceutical industry, and it is recommended for all microbiology libraries. [Subject: Microbiology, Life Science, Medicine]
| Author | : Flavia Marinelli |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 363 |
| Release | : 2013-10-04 |
| Genre | : Medical |
| ISBN | : 3642399681 |
Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the “arms race” with resistant pathogens. This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.
| Author | : Anton Ficai |
| Publisher | : Elsevier |
| Total Pages | : 724 |
| Release | : 2017-05-29 |
| Genre | : Science |
| ISBN | : 0323461514 |
Nanostructures for Antimicrobial Therapy discusses the pros and cons of the use of nanostructured materials in the prevention and eradication of infections, highlighting the efficient microbicidal effect of nanoparticles against antibiotic-resistant pathogens and biofilms. Conventional antibiotics are becoming ineffective towards microorganisms due to their widespread and often inappropriate use. As a result, the development of antibiotic resistance in microorganisms is increasingly being reported. New approaches are needed to confront the rising issues related to infectious diseases. The merging of biomaterials, such as chitosan, carrageenan, gelatin, poly (lactic-co-glycolic acid) with nanotechnology provides a promising platform for antimicrobial therapy as it provides a controlled way to target cells and induce the desired response without the adverse effects common to many traditional treatments. Nanoparticles represent one of the most promising therapeutic treatments to the problem caused by infectious micro-organisms resistant to traditional therapies. This volume discusses this promise in detail, and also discusses what challenges the greater use of nanoparticles might pose to medical professionals. The unique physiochemical properties of nanoparticles, combined with their growth inhibitory capacity against microbes has led to the upsurge in the research on nanoparticles as antimicrobials. The importance of bactericidal nanobiomaterials study will likely increase as development of resistant strains of bacteria against most potent antibiotics continues. Shows how nanoantibiotics can be used to more effectively treat disease Discusses the advantages and issues of a variety of different nanoantibiotics, enabling medics to select which best meets their needs Provides a cogent summary of recent developments in this field, allowing readers to quickly familiarize themselves with this topic area
| Author | : Society for General Microbiology. Symposium |
| Publisher | : Cambridge University Press |
| Total Pages | : 396 |
| Release | : 1995-05-04 |
| Genre | : Medical |
| ISBN | : 9780521481083 |
A look back over the development of antibiotics since Fleming's day and a look forward to future challenges.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 496 |
| Release | : 2011-01-10 |
| Genre | : Medical |
| ISBN | : 0309156114 |
Years of using, misusing, and overusing antibiotics and other antimicrobial drugs has led to the emergence of multidrug-resistant 'superbugs.' The IOM's Forum on Microbial Threats held a public workshop April 6-7 to discuss the nature and sources of drug-resistant pathogens, the implications for global health, and the strategies to lessen the current and future impact of these superbugs.
